Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy

Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy

Objective: Few clinical studies have assessed real-world abrupt transitioning between insomnia medications. This study assessed strategies for directly transitioning patients from zolpidem tartrate (ZOL) immediate/extended release to the dual orexin receptor antagonist, lemborexant (LEM). Methods: T...

Full description

Bibliographic Details
Main Authors: Maha Ahmad, James Kelly, C. Brendan Montano, Dinesh Kumar, Carlos Perdomo, Manoj Malhotra, Jess Amchin, Margaret Moline
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Sleep Medicine: X
Subjects:
Clinical trial
Insomnia
Lemborexant
Orexin
Zolpidem
Online Access:http://www.sciencedirect.com/science/article/pii/S2590142723000381

Internet

http://www.sciencedirect.com/science/article/pii/S2590142723000381

Similar Items